Pestalozzi advises Pactiv Evergreen Inc., a Nasdaq listed company and specialists in the packaging and filling industry, in the sale by one of its carton packaging and filling machinery subsidiaries in China, Korea and Taiwan
Tags :Severin Roelli
Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20
H.C. Wainwright acted as sole placement agent in connection to the private placement of 71,428,572 shares in Relief Therapeutics Holding, a Swiss biopharmaceutical company listed at SIX Swiss Exchange, at a price of CHF 0.21 per
The Pestalozzi team included Christian Leuenberger (Lead Partner - Capital Markets, Corporate/M&A - pictured), Severin Roelli (Partner - Corpoarte/M&A), Manu Ferro (Associate - Banking & Finance).
The team included: Severin Roelli (Partner - Corporate / M&A - pictured), Franz Schubiger (Partner - Corporate / M&A), Christoph Lang (Partner - Competition)
